Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Platelet-rich Plasma for Eyebrows

NCT: NCT04018859 · ACTIVE_NOT_RECRUITING

NCT IDNCT04018859
StatusACTIVE_NOT_RECRUITING
Start Date2019-09-25
Completion2028-12
SponsorNorthwestern University (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of mild to moderate eyebrow hypotrichosis. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with mild to moderate eyebrow hypotrichosis. Approximately 40 subjects will be randomized to receive platelet-rich plasma (PRP) or saline injections. The study is designed as an 9-month study. This study was a pilot study designed to determine feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.

Frequently Asked Questions

What is Platelet-rich Plasma for Eyebrows?

Platelet-rich Plasma for Eyebrows is a clinical trial registered under NCT04018859. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT04018859?

The current status of NCT04018859 (Platelet-rich Plasma for Eyebrows) is: ACTIVE_NOT_RECRUITING.

When did Platelet-rich Plasma for Eyebrows start?

Platelet-rich Plasma for Eyebrows started on 2019-09-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.